Training Network for the education of the next generation scientist in targeting the supressive capacity of regulatory T-cells specifically within tumours

Zaiss, Dietmar (Principal Investigator)

School of Biological Sciences

Status	Finished
Effective start/end date	1/06/18 → 30/11/22

Funding

EU government bodies: £379,567.00

5 Article
1 Review article

In a therapeutic setting, mouse IgG2a isotype is superior to mIgG1 or mIgE in controlling tumor growth
Vukovic, N., Segues Cistero, A., Huang, S., Waterfall, M., Sijts, A. & Zaiss, D., 6 Jan 2023, In: Cancer research communications. 3, 1, p. 109-118 27 p.
Research output: Contribution to journal › Article › peer-review

Open Access
File
Shortened hinge design of Fab x sdAb-Fc bispecific antibodies enhances redirected T-Cell killing of tumor cells
Huang, S., Segués, A., Waterfall, M., Wright, D., Vayssiere, C., Van Duijnhoven, S. M. J., Van Elsas, A., Sijts, A. J. A. M. & Zaiss, D. M., 21 Sept 2022, In: Biomolecules. 12, 10, 16 p., 1331.
Research output: Contribution to journal › Article › peer-review

Open Access
File
Advances in mRNA-based drug discovery in cancer immunotherapy
Di Trani, C. A., Fernandez-Sendin, M., Cirella, A., Segués, A., Olivera, I., Bolaños, E., Melero, I. & Berraondo, P., 20 Sept 2021, (E-pub ahead of print) In: Expert opinion on drug discovery. 46 p.
Research output: Contribution to journal › Article › peer-review

Open Access
File